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geriatric dentistry

The Interprofessional Management of
Geriatric Patients Undergoing Head and Neck
Cancer Treatment in U.S. Nursing Homes
Literature Review
Rashidah Wiley, D.D.S.; Vidushi Gupta, D.M.D.; Riddhi A. Daftary, D.M.D.;
Jessfor Baugh, D.M.D.; Anh H. Tran, D.M.D.; Dorothy Lynne Cataldo, D.M.D.;
Yang Kang, D.D.S., Ph.D.; Takashi Komabayashi, D.D.S., M.D.S., Ph.D.

ABSTRACT
Head and neck malignancies can be difficult to treat, especially in the geriatric population. A dental approach
toward interprofessional management, treatment planning and rehabilitation of diagnosed individuals undergoing cancer therapies is essential. This literature review
focuses primarily on: presurgery oral hygiene instructions; pre-radiotherapy/chemotherapy dental clearance;
complications and management during radiotherapy/
chemotherapy; post-radiotherapy/chemotherapy oral
healthcare; and adjunctive measures. Each section aims
to affirm that thorough evaluation is vital to understanding the assessment and safe management of patients undergoing oncology treatment. Furthermore, this project
will help establish guidelines for interprofessional nursing home teams in regards to oral healthcare.
Head and neck cancer (HNC) constitutes less than 5% of all
cancers, but it can have devastating outcomes in the lives of affected patients.1-2 In 2001, there were approximately 30,000 HNCrelated deaths in the United States.1 It has been linked to several
causes, including tobacco use and/or alcohol consumption.

Eighty percent to ninety percent of head and neck cancers are due
to tobacco and alcohol use. Traditionally, men over the age of 40
who smoke have the highest risk of developing HNC, squamous
cell carcinoma (SCC). A recent study showed that development
of oral cancer in smokers increases with age. Men who stopped
smoking at 30 years of age had a 1.2% risk of developing SCC,
while men 75 years of age and older who continued smoking had
a 6.3% risk of developing cancer of the upper digestive tract.1
The incidence of human papilloma virus (HPV)-related
squamous cell carcinoma has increased in the last 20 to 30 years.
This disease usually occurs in the region of the oropharynx in
patients who are 45 years or younger, so it is not usually a risk
factor in the geriatric population. HPV-related SCC is discovered
at a later stage, but it responds better to radiation treatment compared to non-HPV-related squamous cell carcinoma. Deficiencies
of vitamin A and iron, occupational exposure to toxic chemicals
and genetic abnormalities have also been linked to the development of cancer in the head and neck.2 Immunosenescence, which
is defined as the changes that occur in the immune system due to
increased age, may cause an increase in the risk of cancer.3
It has been postulated that by the year 2030, 20% of the
overall population will be composed of individuals 65 years and
older.4 The elderly, in particular, are at risk of developing cancer
throughout the body, including the head and neck region. According to the American Cancer Society, people ages 55 and above
represent 78% of all cancer diagnoses.5 Treatment modalities for
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cancer, such as surgery, radiation and/or chemotherapy, can take

nd Gillen 7/5/11 7:46
AM Page psychological
1
a physical,
and financial toll on the affected indi-

viduals.6 Support from family, friends and nursing home staff can
help these patients learn how to cope with their illness.
Nursing homes are facilities that provide long-term residential accommodations and/or healthcare for patients who do not
require hospitalization but do require 24-hour assistance.6-11 According to the Centers for Disease Control and Prevention, in
2013, the United States had 15,700 nursing homes, with 1.4
million beds out of a possible 1.7 million being occupied. While
nursing homes provide healthcare to ensure a better quality of
life, oral care has been found to be a low priority.6 Nurses form
an integral part of the interdisciplinary team caring for patients
before, during and after treatment.6 Dental professionals can assist nurses with patients living in these facilities.
For this study, the journals reviewed were published in English between 1975 and 2015 and contained information about
the various types of cancers that occur in the head and neck
region, along with treatment modalities and complications.
Literature regarding dental care in nursing homes was also included. Abstracts and continuing education course materials
were excluded. Relevant websites and textbooks with informa-
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tion related to the incidence of cancer and the care of affected
patients were also used. This review will discuss pre-surgery oral
hygiene instructions, pre-radiology/chemotherapy dental clearance, during-radiology/chemotherapy dental complications and
management, post-radiology/chemotherapy oral healthcare and
adjunctive healthcare. The aim of this review is to explore guidelines for nursing home healthcare teams in regards to oral health
and interprofessional collaboration.
Presurgery Oral Hygiene
The healthcare team at a nursing home comprises family, physicians, nursing staff, social workers, rehabilitation staff, physical
therapists, occupational therapists, speech therapists and other
non-medical personnel.6,12
As the population ages, physician visits increase, while dental visits decrease for reasons ranging from the individual’s lack
of awareness, changes in oral hygiene habits and inability to afford dental care.7 The nursing home staff may require more encouragement in recognizing the importance of oral care in older
populations. According to a study by Coleman and Watson, five
nursing homes in New York State did not meet oral hygiene standards for their residents, such as brushing their teeth for at least
two minutes, flossing, performing an oral assessment, rinsing
with mouthwash and wearing gloves during the performance of
oral care.13 The elderly are particularly at risk for the development
of oral diseases that are gateways to other systemic disease, such
as cardiovascular disease, stroke and respiratory infection.14 Thus,
it is extremely important for the team at the nursing home to administer a rigorous oral care protocol. One of the most effective
ways to ensure change is to include interdisciplinary collaboration between nurses and dental professionals.
The risk of squamous cell carcinoma increases after age
65, so it is important that all staff be aware of the clinical
manifestations. These include red and white mucosal lesions
that cannot be wiped away and which should undergo biopsy
if present for more than two weeks.3 Non-healing ulcers present for more than two weeks should also be biopsied.2 HNC
may present as ominous-appearing nodular growths, palpable
swellings, constant sore throat and otitis media that do not
respond to antibiotics, as well as non-trauma-induced and uncontrolled bleeding of the mucosa.2
Once a patient has been diagnosed with cancer, it is important to increase oral hygiene measures. Cancer therapy can cause
the oral cavity to undergo many changes, so it is best to establish a
good regimen. Patients should be encouraged to cease all high-risk
behaviors, such as smoking and excessive alcohol consumption.
Dental Clearance prior to Radiation and Chemotherapy
A comprehensive oral evaluation, prior to HNC treatment, is necessary to identify and eliminate active or potential oral sources

TABLE 1.
Oral and Dental Care Prior to Cancer Therapy
Dental Care Considerations

Guidelines and Action

Surgical Considerations

Vital and viable teeth should be retained for function, aesthetics, and quality of life.70 Nonetheless, it is significant to
eliminate possible sources of infection.28
Due to the increased risk of osteoradionecrosis in irradiated bone with dental extractions or untreated infection, it is
generally advised to extract teeth with poor long-term prognosis prior to radiotherapy.71 Ideally, extractions should be
undertaken up to two weeks before commencement of radiotherapy.28,72 Teeth that should be considered for extraction
include, but are not limited to:70
●
Extensive carious lesions with questionable pulpal status or involvement
●
Extensive peri-apical lesions
●
Moderate or advanced periodontal disease, with extensive attachment loss, bone loss and mobility or furcation involvement
●
Residual root tip that is radiolucent or if not fully covered by alveolar bone
●
Impacted or incompletely erupted teeth (third molars)71, 73, 74

Periodontal Considerations

Scaling and prophylaxis with establishment and reinforcement of good oral hygiene and dietary advice. With emphasis
on adequate hydration.75
Deep scaling and root planing (PD < 6 mm) should occur 14 days prior to radiotherapy for sufficient healing time.28
Recommended mouthrinse with aqueous alcohol-free chlorhexidine gluconate mouthwash for short-term use.

●

Restorative Treatment

Caries removal and restorations.
Smoothing of irregular teeth and sharp areas on restoration. Removal and replacement of defective restorations.74

Prosthetic Considerations

Removable prostheses should be removed if any signs of ulceration.
Ill-fitting dentures should be relined, repaired, or replaced to avoid irritation and tissue trauma.23

Orthodontic Appliances

Treatment should be discontinued.76

of infection. In cancer patients, the most frequently documented
source of sepsis is the oral cavity.15-20 Therefore, it is essential to
evaluate and address dental needs for geriatric patients receiving oncology treatment. An early assessment of oral status and a
means for providing care are critical in reducing potential complications associated with cancer therapy.17
Pre-treatment Comprehensive Oral Evaluation
Ideally, the oral evaluation should occur several weeks prior to
commencement of cancer treatment, to allow for adequate healing time.18,21,22 Medical consultation and thorough review of the
patient’s dental history are needed to develop an appropriate
treatment plan. The medical consultation should encompass information concerning the disease/condition and associated treatment protocol, immunosuppression status, medications, allergies
and contact information for the patient’s oncologist.17,23
Dental health history must contain information regarding the
patient’s previous dental care, symptomatic teeth, trauma, habits,
fluoride exposure, caries risk assessment and oral hygiene.16 The
assessment includes extraoral and intraoral clinical examinations,
identification of existing infections and other compromised hard
or soft issues, and an evaluation of relevant radiographs.16,24
Dental and Systemic Care prior to Oncology Therapy
Upon completion of the oral examination, it is critical that the
dentist communicate the findings and associated treatment plan

to the oncologist. If the radiation oncologist determines that a delay in cancer treatment will affect the potential success of disease
control and patient survivability, pre-cancer dental care may not
be advisable.25,26 The main focus should be on existing infections,
extractions, periodontal care and sources of tissue irritation
(Table 1).16,24,27,28 The team should educate the patient on proper
oral hygiene, maintenance, nutrition and diet.24 Oral and maxillofacial surgeons (OMS) play an important role in diagnosing HNC
and patient management. The OMS is involved with cancer screenings and patient education, and surgical therapy.29,30 The team approach will aid in reducing or eliminating complications, such as
radiation mucositis, xerostomia and osteoradionecrosis.31,32
In addition to a complete oral examination, a comprehensive geriatric assessment (CGA) should be completed.33 Geriatric
patients often present with comorbidities, such as narrow arteries and decreased organ function, which may cause complications
during surgery, radiation and chemotherapy. Chemotherapyrelated toxicity is more common in elderly patients. This is caused
by decreased liver and renal function, which allows abnormally high
levels of chemotherapeutics to build up in the bloodstream.29,30,33
CGA is a multidiscplinary evaluation of the patient’s nutritional
status, co-morbid medical conditions, cognition, psychological
state and functional status. This assessment will help determine
what type of treatment the patient will be able to withstand.33 Systemic health benefits and oral care are critical to the quality of life
for geriatric patients undergoing oncology treatment.34
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Dental Complications and Management
during Radiation/Chemotherapy Treatment
Oral or oropharyngeal mucositis (OM), an inflammatory disease
of the oral and oropharyngeal mucosa, is commonly induced by
ionizing radiation during radiation therapy (RT). Within three
weeks, mucosal ulcerations manifest and become confluent.35
These ulcerations may persist for up to six weeks after completion
of RT and impair the patient’s ability to eat, speak and function
properly. These lesions leave patients vulnerable to microbial invasion of the bloodstream, increasing their risk of acquiring local
or systemic infections.36,37
Therapeutic treatments, including soft laser and cryotherapy, show increasing evidence of effectiveness in preventing and
managing OM. Lack of significant evidence, however, has limited
their approval or utilization.
OM treatment is associated with symptom management.38
As pain is typically present, treatment begins with topical analgesics or anesthetics, such as viscous lidocaine to help with OM.15
Some clinicians will prescribe “magic mouthwash” to alleviate
the pain associated with OM. There are many different formulas used to make magic mouthwash. Palifermin is the only FDAapproved growth factor or cytokine-approved medication to treat
oral mucositis.39-41 Alternating non-opioid oral analgesics, such
as ibuprofen and Tylenol, is recommended if topical application is
insufficient. If pain persists, opioids may be added, starting with
the lowest effective dose and increasing as needed.38,42
Low-level laser therapy (LLLT) is a new modality, which
may be used to reduce the effects of mucositis in patients treated
with RT.15,33,43 In a recent study by Gautam et al., LLLT treatment of the oral cavity prior to RT showed decreased OM, oral
pain, weight loss and the need for analgesic in elderly patients
with HNC.15,43
Xerostomia
Salivary glands are sensitive to RT. Xerostomia may manifest due
to inflammation, fibrosis or degeneration of salivary glands. Decreased flow is continuous throughout RT and may persist posttreatment, increasing the risk of infections and the development of
dental caries.36 Current treatments for xerostomia hope to increase
the existing salivary flow or replace lost secretions, maintain proper
oral hygiene, control dental caries that may be present and treat
any arising infections. The presence or absence of residual oral cavity secretions determines appropriate treatment.42
Xerostomia treatments include muscarinic acetylcholine
agonists, salivary substitutes or stimulants, acupuncture and hyperbaric oxygen therapy (HBOT). Some examples of muscarinic
acetylcholine agonists are pilocarpine and cevimeline. The continued administration of topical pilocarpine lozenges has been
found to be superior to other treatments for improving unstimulated and stimulated salivary flow rates.44
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Alternative treatments include mechanical, gustatory or electrical salivary stimulants. If salivary secretion stimulation fails,
mouthwash or saliva substitutes that mimic natural saliva may
be prescribed. Because of the increased risk for dental caries
and infections, patients require frequent dental visits. Patients
must be active in managing xerostomia by performing daily selfexaminations for the presence of any white, red or dark-pigmented
lesions, ulcerations or tooth decay.42,44
Infections
Radiation-induced xerostomia and mucosal ulcerations increase
the risk of viral, bacterial or fungal infections. Common bacterial
infections involve species of Staphylococci and Streptococci, Klebsiella pneumonia, Pseudomonas aeruginosa and Escherichia coli.45 The
most common infection is oral candidiasis (OC), an opportunistic
fungal infection primarily associated with Candida albicans. The
two types of acute OC found in this population are pseudomembranous and erythematous. Patients suffering from pseudomembranous OC may present with wipeable, white, patchy lesions,
while erythematous OC manifests in the oral cavity as red diffused lesions on the oral mucosa. Frequently coexisting during
RT, OC is often mistaken as oropharyngeal mucositis. Common
symptoms are generalized burning sensations and pain.35,46
The treatment for OC is topical antifungal medication. Systemic antifungals are administered for more invasive infections.
Antifungal agents that are fully absorbed from the GI tract, such
as fluconazole, ketoconazole and itraconazole, appear to be more
effective in preventing OC.44,47
Trismus and Fibrosis
Radiation-induced fibrosis and ischemia may lead to trismus during or post-RT. Unmanaged trismus may cause difficulty in swallowing. The main treatment for increasing mouth-opening is a
constant exercise regimen.37 Nursing home patients experiencing difficulty with exercising independently may manage exercise
routines with the help of staff. Modified, custom-made mouthopening devices could be an alternative treatment.48
Post-radiation/chemotherapy
Complications and Management
Long-term complications of radiotherapy and chemotherapy include xerostomia, osteoradionecrosis, rampant caries and radiationinduced sarcomas. Severe cases of xerostomia can cause difficulty in
speech and swallowing, making everyday tasks troublesome.49
Residents in nursing homes might experience extreme discomfort with removable prostheses because saliva promotes
bonding between the interface of prosthesis and the oral/gingival tissue.50,51 Xerostomia treatment includes salivary stimulants,
mouth moisteners and parasympathomimetic drugs. Side effects
might be sweating, headache, rhinitis, dizziness and urinary fre-

quency.52-56 Persistent xerostomia can lead to rampant caries.
Effective preventive therapies include maintenance of good oral
hygiene, the use of fluoride and chlorhexidine rinse.52 Conventional glass ionomers are the restorative material of choice because of their bond strength and fluoride release.25
Most cases of osteoradionecrosis occur as the result of traumatic incidents, such as tooth extraction, biopsies, periodontal
disease, subgingival scaling or ill-fitting prostheses.20 After radiotherapy, edentulous patients should not wear dentures for at least
one year. Dental implants can be placed successfully in irradiated bone 12 to 18 months after completion of radiotherapy.58
Although rare, treatment with radiation can cause post-radiation
sarcomas.57 Therefore, any suspicious lesion should be sent for
biopsy. If the lesion is found to be malignant, surgical resection
is often the main treatment of choice.51 The oral and maxillofacial surgeon can aid in post-radiation/chemotherapy therapy by
helping patients through the rehabilitation process.29,30
Prostheses are essential to help patients regain normal function and improve facial aesthetics. Prostheses include dentures, as
well as treatments for other portions of the face and neck. Because
tissues actively heal and change after surgery, a close follow-up of
the fit of the prostheses and assessment of functional jaw improvement is recommended.59 Patients, with the help of the nursing staff, should perform frequent oral examinations to identify
any abnormal changes occurring in the oral cavity.15 The dentist
can help by performing monthly oral examinations for residents
for the first six months after completion of their treatment(s)
and semiannually thereafter.59 An oral medicine specialist should
be notified whenever oral pathology is suspected.15

and reduce inflammation, hypoxia and contractile tensions.61 A
novel technique is trigger-point dry-needling, which decreases
pain and increases cervical ROM and blood flow to the site in
patients having upper myofascial pain.62 Various jaw ROM exercises and mechanical assistance devices, such as Therabite (Atos
Medical, Sweden), can help increase ROM.63 Fibrosis can result in
impaired movement of the muscles of mastication, tongue, pharyngeal constrictors and larynx, resulting in swallowing dysfunction and risk for aspiration.63-65 Tongue-stretching, as an adjunct
to the supraglottic swallowing maneuver, helps with coordination
of chewing and swallowing.63
Prevention counseling in oral hygiene, nutrition, alcohol and
smoking should be offered. Smoking after a cancer diagnosis decreases the effectiveness of radiotherapy, shortens survival time
and increase the risks of recurrence, second primary malignancies and treatment complication.65 Cryotherapy (e.g., sucking
on ice chips) can also lower the incidence of mucositis during
infusions of chemotherapeutic agents by causing local vasoconstriction, thus reducing exposure of cells to the drug.39,63 Pain
associated with mucositis can be alleviated by using mouthrinses
(Table 2) and gargling several times a day with warm salt water or
a baking soda solution.66

Adjunctive Treatment
Innovative cancer treatments are keeping patients alive longer,
resulting in complex disabilities, including fibrosis of irradiated
tissue, trismus, dermatitis, and severe, acute mucositis and oropharyngeal.53,56 Radiation-induced tissue damage occurs from
injury to the endothelial cells lining small blood vessels, resulting in inflammation, ischemia and interstitial edema.60 Edema
in the head and neck causes facial disfigurement; in severe cases,
swelling of eyelids and lips can lead to difficulties in eating, as
well as impaired vision.55 Traditional nursing measures, such as
compression garments, ambulation and elevation, contribute to
a reduction in lymphedema. Radiation dermatitis symptoms may
be alleviated by skin care instructions, the use of aloe vera gels
and water-based lotions, avoiding chemical irritants, and limiting
sun and wind exposure. Massage and position changes can alleviate the pressure sores of bedridden patients.60
Patients should be aware of support services, such as physical,
manual and occupational therapy, to reduce deconditioning and
muscle atrophy. Manual therapy includes passive/active stretching and joint manipulation to increase range of motion (ROM)
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TABLE 2.
Natural Adjunctive Mouthrinse Recommendations for Mucositis
Secondary to Chemotherapy and/or Radiation for Cancer Treatment
Management/Therapy

Patient Diagnosis

Results

Type Study/Level Evidence

Author/Year

Rinse containing olive leaf
extract (OLE) or benzydamine
hydrochloride

Chemotherapy-induced
mucositis—25 patients given
mouthrinse with OLE, 25
patients given mouthrinse with
benzydamine hydrochloride,
25 patients given placebo
mouthrinse.

Oral mucositis rates and severity
were lower in OLE and Benzydamine groups compared to placebo.
Decrease in pro-inflammatory
cytokine production.

Double-blind RCT, Level I

Ahmed (2012)64

Calendula officinalis (English
marigold) flowers extract
mouthwash as oral gel on
radiation-induced oropharyngeal mucositis (OM)

38 patients with HNC undergoing radiotherapy (60 Gy)
or concurrent chemoradiotherapy were randomly assigned
to receive either 2% calendula
extract mouthwash or placebo
(20 patients in each group).

OMAS scores were significantly
lower in calendula group compared to placebo at week 2, 3
and 6 of the study.

RCT, Level I

Babaee (2013)77

Korean red ginseng
(liquid concentrate) only

(20 Gy) Radiation-induced
oral mucositis.

Rats in RT+ KRG group had less
severe mucositis, fewer ulcerative
mucosal lesions on the tongue, less
hair loss, less rapid decrease in
weight than did the RT-only group.

RCT, Level I

Chang (2014)78

Dioctahedral smectite
(natural absorbent clay
of non-systemic specific
aluminomagnesium silicate)
and iodine glycerin (DSIG)
cream vs. topical mouthrinse
(composed of saline,
gentamicin and Vitamin B

18 y.o. and older with
pathological confirmed
malignant tumors or malignant
hematological diseases,
130 intensive chemotherapy
or stem cells transplantation
induced OM. 67 patients
received topical mouthrinse
and 63 patients received
DSIG cream treatment.

A favorable, lower oral assessment guideline (OAG) score was
observed in DSIG cream treated
patients. The iodine glycerin may
function as an antifungal/antibacterial and decrease repair time.
From day 2-5 topical mouthrinse
patients had a higher OAG score
than DSIG treated. “The mouthrinse
shows a protective function prior to
OM appearance.”

Prospective RCT, Level I

Lin (2015)79

Curcumin mouthwash

20 adult cancer patients
with radio-chemotherapy
OM randomly divided into
2 groups.

Curcumin mouthwash was found
to be better than chlorhexidine
mouthwash in terms of rapid
wound healing and better
patient compliance.

RCT, Level I

Patil (2015)80

13 received an aloe vera
mouthwash, 13 received
benzydamine mouthwash.

26 HNC patients
(receiving at least 50 Gy)
with radiation-induced
mucositis.

Aloe vera mouthwash was as
beneficial as benzydamine mouthwash in alleviating the severity of
radiation-induced mucositis and
showed no side effects.

Triple Blind RCT, Level I

Sahebjamee (2015)81

16 received polaprezinc,
15 received azulene oral
rinse (control).

31 HNC patients
with radiotherapy or
radiochemotherapy OM.

Incidence rate of mucositis, pain,
xerostomia and taste disturbance
was lower in polaprezinc group
than control.

Prospective RCT, Level I

Watanabe (2010)82

Radiotherapy only
RT+ KRG group

RCT: Randomized Control Trial
Gy: Grays
OMAS: Oral Mucositis Assessment Scale
HNC: Head and Neck Cancer
OM: Oropharyngeal Mucositis
KRG: Korean Red Ginseng
RT: Radiation therapy
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According to repeated measures
ANOVA test, the differences
between OMAS of calendula and
placebo during the weeks of evaluation were statistically significant
(p < 0.001).

HNC patients are at high risk for malnutrition due to taste alterations, xerostomia from medications, parotid atrophy and radiation-induced diarrhea (RID).65,66 The diagnosis of diminished
swallowing function and odynophagia (painful swallowing) can be
made by a speech language pathologist and treated by means of postures to control the bolus and other swallowing maneuvers. Twentynine percent to sixty-six percent of patients will experience severe
oral mucositis during treatment, which is why alternative ways to
provide nutrition need to be found.67 Bolus modification by altering
foods (mashed, puréed, thickened [fluids]) may make them safer to
swallow.68 Feeding tubes can also offer additional nutritional support post-treatment, when oral consumption is too painful.
Psychological support and speech rehabilitation can greatly
improve the HNC patient’s mental health. Frequently used alternatives include selenium, relaxation techniques, prayer, vitamin C, meditation and distraction.69 Mild-to-moderate exercise
can promote energy and boost quality of life and mood, despite
feelings of tiredness.70 Care plans should be tailored to meet the
needs of each individual.
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Conclusion
The objective of this review is to stress the importance of interprofessional collaboration and management for the treatment of
patients undergoing various types of cancer therapy. Each healthcare provider has the knowledge to guide the geriatric population
in nursing homes through the various phases of diagnosis, treatment and health maintenance post-treatment. The dentist and
allied dental health professional can assist the nursing home staff
with patients’ oral hygiene and look for signs of recurrent disease.
The goal of the interprofessional team is to increase overall health
and quality of life. p
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